tiprankstipranks
Trending News
More News >
Neurogene’s Promising Outlook: Buy Rating Backed by Robust Financials and Upcoming Clinical Milestones
PremiumRatingsNeurogene’s Promising Outlook: Buy Rating Backed by Robust Financials and Upcoming Clinical Milestones
1M ago
Neurogene Reports 2024 Financial Results and Advances in Rett Syndrome Trial
Premium
Company Announcements
Neurogene Reports 2024 Financial Results and Advances in Rett Syndrome Trial
1M ago
Neurogene’s Promising Clinical Progress and Financial Stability Earns Buy Rating
Premium
Ratings
Neurogene’s Promising Clinical Progress and Financial Stability Earns Buy Rating
1M ago
Neurogene files to sell 4M shares of common stock for holders
PremiumThe FlyNeurogene files to sell 4M shares of common stock for holders
5M ago
3 Stocks to Buy Now, 12/2/2024, According to Corporate Insiders
Premium
Market News
3 Stocks to Buy Now, 12/2/2024, According to Corporate Insiders
5M ago
Neurogene Adjusts Clinical Trial After Setback
Premium
Company Announcements
Neurogene Adjusts Clinical Trial After Setback
5M ago
Neurogene selloff on safety event an overreaction, says H.C. Wainwright
PremiumThe FlyNeurogene selloff on safety event an overreaction, says H.C. Wainwright
5M ago
Closing Bell Movers: Super Micro up 28% on compliance update
Premium
The Fly
Closing Bell Movers: Super Micro up 28% on compliance update
5M ago
Neurogene reports Q3 EPS ($1.19), consensus ($1.22)
Premium
The Fly
Neurogene reports Q3 EPS ($1.19), consensus ($1.22)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100